Publication Information

{'id': 'https://openalex.org/W2077649377', 'doi': 'https://doi.org/10.1007/s13277-014-1635-4', 'title': 'The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials', 'display_name': 'The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials', 'publication_year': 2014, 'publication_date': '2014-02-25', 'ids': {'openalex': 'https://openalex.org/W2077649377', 'doi': 'https://doi.org/10.1007/s13277-014-1635-4', 'mag': '2077649377', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24570182'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1007/s13277-014-1635-4', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S12644804', 'display_name': 'Tumor Biology', 'issn_l': '1010-4283', 'issn': ['1010-4283', '1423-0380'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100329054', 'display_name': 'Xuan Wang', 'orcid': 'https://orcid.org/0009-0004-9946-5592'}, 'institutions': [{'id': 'https://openalex.org/I2802573037', 'display_name': 'Tianjin Medical University Cancer Institute and Hospital', 'ror': 'https://ror.org/0152hn881', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802573037']}, {'id': 'https://openalex.org/I4210126592', 'display_name': 'National Clinical Research', 'ror': 'https://ror.org/03ddkvp86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210126592']}, {'id': 'https://openalex.org/I5740404', 'display_name': 'Tianjin Medical University', 'ror': 'https://ror.org/02mh8wx89', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I5740404']}], 'countries': ['CN', 'US'], 'is_corresponding': False, 'raw_author_name': 'Xuan Wang', 'raw_affiliation_strings': ['Tianjin Medical University', 'Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer'], 'affiliations': [{'raw_affiliation_string': 'Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer', 'institution_ids': ['https://openalex.org/I2802573037', 'https://openalex.org/I4210126592']}, {'raw_affiliation_string': 'Tianjin Medical University', 'institution_ids': ['https://openalex.org/I5740404']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101846124', 'display_name': 'Chun Huang', 'orcid': 'https://orcid.org/0000-0002-3626-7140'}, 'institutions': [{'id': 'https://openalex.org/I4210126592', 'display_name': 'National Clinical Research', 'ror': 'https://ror.org/03ddkvp86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210126592']}, {'id': 'https://openalex.org/I2802573037', 'display_name': 'Tianjin Medical University Cancer Institute and Hospital', 'ror': 'https://ror.org/0152hn881', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802573037']}, {'id': 'https://openalex.org/I5740404', 'display_name': 'Tianjin Medical University', 'ror': 'https://ror.org/02mh8wx89', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I5740404']}], 'countries': ['CN', 'US'], 'is_corresponding': False, 'raw_author_name': 'Chun Huang', 'raw_affiliation_strings': ['Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer', 'Tianjin Medical University, Ministry of Education'], 'affiliations': [{'raw_affiliation_string': 'Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer', 'institution_ids': ['https://openalex.org/I4210126592', 'https://openalex.org/I2802573037']}, {'raw_affiliation_string': 'Tianjin Medical University, Ministry of Education', 'institution_ids': ['https://openalex.org/I5740404']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108049291', 'display_name': 'Man Li', 'orcid': 'https://orcid.org/0000-0002-5710-5175'}, 'institutions': [{'id': 'https://openalex.org/I2802573037', 'display_name': 'Tianjin Medical University Cancer Institute and Hospital', 'ror': 'https://ror.org/0152hn881', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802573037']}, {'id': 'https://openalex.org/I4210126592', 'display_name': 'National Clinical Research', 'ror': 'https://ror.org/03ddkvp86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210126592']}], 'countries': ['CN', 'US'], 'is_corresponding': False, 'raw_author_name': 'Man Li', 'raw_affiliation_strings': ['Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer'], 'affiliations': [{'raw_affiliation_string': 'Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer', 'institution_ids': ['https://openalex.org/I2802573037', 'https://openalex.org/I4210126592']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101062095', 'display_name': 'Yanjun Gu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4396570617', 'display_name': "Chinese People's Armed Police Force", 'ror': 'https://ror.org/011gh0524', 'country_code': None, 'type': 'government', 'lineage': ['https://openalex.org/I4210133972', 'https://openalex.org/I4396570617']}], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Yanjun Gu', 'raw_affiliation_strings': ['Medical College of the Chinese People’s Armed Police Forces'], 'affiliations': [{'raw_affiliation_string': 'Medical College of the Chinese People’s Armed Police Forces', 'institution_ids': ['https://openalex.org/I4396570617']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020316684', 'display_name': 'Yanfen Cui', 'orcid': 'https://orcid.org/0000-0001-6631-5687'}, 'institutions': [{'id': 'https://openalex.org/I2802573037', 'display_name': 'Tianjin Medical University Cancer Institute and Hospital', 'ror': 'https://ror.org/0152hn881', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802573037']}, {'id': 'https://openalex.org/I4210126592', 'display_name': 'National Clinical Research', 'ror': 'https://ror.org/03ddkvp86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210126592']}], 'countries': ['CN', 'US'], 'is_corresponding': False, 'raw_author_name': 'Yanfen Cui', 'raw_affiliation_strings': ['Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer'], 'affiliations': [{'raw_affiliation_string': 'Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer', 'institution_ids': ['https://openalex.org/I2802573037', 'https://openalex.org/I4210126592']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5100380374', 'display_name': 'Yan Li', 'orcid': 'https://orcid.org/0000-0002-6857-9464'}, 'institutions': [{'id': 'https://openalex.org/I2802573037', 'display_name': 'Tianjin Medical University Cancer Institute and Hospital', 'ror': 'https://ror.org/0152hn881', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802573037']}, {'id': 'https://openalex.org/I4210126592', 'display_name': 'National Clinical Research', 'ror': 'https://ror.org/03ddkvp86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210126592']}], 'countries': ['CN', 'US'], 'is_corresponding': False, 'raw_author_name': 'Yan Li', 'raw_affiliation_strings': ['Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer'], 'affiliations': [{'raw_affiliation_string': 'Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer', 'institution_ids': ['https://openalex.org/I2802573037', 'https://openalex.org/I4210126592']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2000, 'currency': 'USD', 'value_usd': 2000, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.185, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 6, 'citation_normalized_percentile': {'value': 0.241708, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '35', 'issue': '5', 'first_page': '4841', 'last_page': '4848'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.997, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Colorectal Cancer Treatments and Studies', 'score': 0.9943, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/progression-free-survival', 'display_name': 'Progression-free survival', 'score': 0.45319876}], 'concepts': [{'id': 'https://openalex.org/C2777802072', 'wikidata': 'https://www.wikidata.org/wiki/Q413299', 'display_name': 'Bevacizumab', 'level': 3, 'score': 0.94483507}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.90010643}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.8340349}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.78020215}, {'id': 'https://openalex.org/C2777292972', 'wikidata': 'https://www.wikidata.org/wiki/Q423762', 'display_name': 'Paclitaxel', 'level': 3, 'score': 0.76882875}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.75385046}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.62047046}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.60906714}, {'id': 'https://openalex.org/C95190672', 'wikidata': 'https://www.wikidata.org/wiki/Q815382', 'display_name': 'Meta-analysis', 'level': 2, 'score': 0.5587841}, {'id': 'https://openalex.org/C2780739268', 'wikidata': 'https://www.wikidata.org/wiki/Q2112244', 'display_name': 'Progression-free survival', 'level': 3, 'score': 0.45319876}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.45262808}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4239063}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D018719', 'descriptor_name': 'Receptor, ErbB-2', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': True}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068258', 'descriptor_name': 'Bevacizumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000401', 'qualifier_name': 'mortality', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018719', 'descriptor_name': 'Receptor, ErbB-2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1007/s13277-014-1635-4', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S12644804', 'display_name': 'Tumor Biology', 'issn_l': '1010-4283', 'issn': ['1010-4283', '1423-0380'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24570182', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.81, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 26, 'referenced_works': ['https://openalex.org/W1925212740', 'https://openalex.org/W1976585485', 'https://openalex.org/W1977490786', 'https://openalex.org/W1978138543', 'https://openalex.org/W1996761484', 'https://openalex.org/W2003278673', 'https://openalex.org/W2009348503', 'https://openalex.org/W2019606818', 'https://openalex.org/W2019801860', 'https://openalex.org/W2037761545', 'https://openalex.org/W2053864737', 'https://openalex.org/W2085992950', 'https://openalex.org/W2088095316', 'https://openalex.org/W2099824657', 'https://openalex.org/W2100608628', 'https://openalex.org/W2103563357', 'https://openalex.org/W2107328434', 'https://openalex.org/W2125435699', 'https://openalex.org/W2126275851', 'https://openalex.org/W2130334661', 'https://openalex.org/W2142760959', 'https://openalex.org/W2143844247', 'https://openalex.org/W2154200023', 'https://openalex.org/W2163003060', 'https://openalex.org/W2169210177', 'https://openalex.org/W2183013425'], 'related_works': ['https://openalex.org/W2891273047', 'https://openalex.org/W2510005223', 'https://openalex.org/W2328551487', 'https://openalex.org/W2328298882', 'https://openalex.org/W2163003060', 'https://openalex.org/W2091442233', 'https://openalex.org/W2080607747', 'https://openalex.org/W2077649377', 'https://openalex.org/W2035195370', 'https://openalex.org/W2033027303'], 'abstract_inverted_index': {'Although': [0], 'both': [1, 180], 'bevacizumab': [2, 53, 76, 120], 'and': [3, 62, 93, 121, 184], 'paclitaxel': [4, 56, 78, 122], 'significantly': [5, 123], 'improve': [6], 'the': [7, 50, 104, 125, 164], 'efficacy': [8, 51], 'of': [9, 52, 110, 119, 166], 'chemotherapy': [10], 'for': [11, 67], 'human': [12], 'epidermal': [13], 'growth': [14], 'factor': [15], 'receptor': [16], '2': [17], '(HER2)-negative': [18], 'patients': [19], 'with': [20, 28, 40, 55, 81, 107, 176], 'metastatic': [21, 173], 'breast': [22, 174], 'cancer': [23], '(MBC),': [24], 'little': [25], 'have': [26, 34], 'changed': [27], 'overall': [29, 87], 'survival': [30, 88, 91, 183], 'rates': [31], 'when': [32], 'they': [33], 'been': [35], 'used': [36], 'alone': [37], 'or': [38], 'combined': [39, 54], 'other': [41, 82], 'chemotherapy.': [42, 83], 'Thus,': [43], 'a': [44, 108], 'meta-analysis': [45, 162], 'was': [46, 193], 'conducted': [47], 'to': [48, 71], 'evaluate': [49], 'in': [57, 74, 170, 179], 'HER2-negative': [58], 'MBC': [59], 'patients.': [60, 112], 'Pubmed': [61], 'Embase': [63], 'were': [64, 79], 'systematically': [65], 'reviewed': [66], 'studies': [68], 'published': [69], 'up': [70], 'September': [72], '2013': [73], 'which': [75], 'plus': [77], 'compared': [80], 'Primary': [84], 'outcomes': [85], 'comprised': [86], '(OS),': [89], 'progression-free': [90], '(PFS),': [92], 'objective': [94, 185], 'response': [95, 186], 'rate': [96], '(ORR).': [97], 'Eight': [98], 'phase': [99], 'II/III': [100], 'clinical': [101], 'trials': [102], 'met': [103], 'inclusion': [105], 'criteria,': [106], 'total': [109], '3,758': [111], 'The': [113, 161], 'pooled': [114], 'results': [115], 'showed': [116], 'that': [117], 'combination': [118, 168], 'improved': [124], 'PFS': [126], '(HR': [127, 152], '=': [128, 134, 138, 144, 153, 159], '0.63,': [129], '95%': [130, 140, 155], 'CI,': [131, 141, 156], '0.55-0.73,': [132], 'P': [133, 143, 158], '0.011),': [135], 'ORR': [136], '(RR': [137], '1.28,': [139], '0.96-1.70,': [142], '0.0),': [145], 'but': [146], 'had': [147], 'no': [148, 189], 'effect': [149], 'on': [150], 'OS': [151, 191], '0.91,': [154], '0.81-1.01,': [157], '0.855).': [160], 'confirms': [163], 'benefits': [165], 'bevacizumab-paclitaxel': [167], 'therapy': [169], 'HER2': [171], 'negative': [172], 'cancer,': [175], 'an': [177], 'improvement': [178], 'progression': [181], 'free': [182], 'rate.': [187], 'However,': [188], 'significant': [190], 'benefit': [192], 'observed.': [194]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2077649377', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 2}], 'updated_date': '2024-12-15T07:41:48.816096', 'created_date': '2016-06-24'}